Navigation Links
Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
Date:2/10/2008

- Dr. Benjamin Ascher, a Leading French Plastic Surgeon, Will Present his UltraShape Clinical Results at the International Society of Aesthetic

Plastic Surgery Meeting in Melbourne, AU From Feb. 10-13

YOQNEAM, Israel and SAN RAMON, Calif., Feb. 10 /PRNewswire/ -- Renowned French Plastic Surgeon, Dr. Benjamin Ascher will present his latest findings from clinical experience with UltraShape(TM) Contour I at the 19th annual International Society of Aesthetic Plastic Surgery (ISAPS) meeting to be held in Melbourne, Australia from February 10-13. UltraShape is the clinically proven non-invasive solution for fat reduction and body contouring using "non- thermal" selective focused ultrasound technology.

Dr. Benjamin Ascher of the Clinique of Aesthetic Surgery IENA in Paris, France, and Course Director the IMCAS Congresses (International Master Course on Aging Skin and Aesthetic Surgery), will present his two most recent clinical trials. The first clinical trial (carried out from January through October 2006) involved 130 patients. Results demonstrated that following a three-treatment protocol using the UltraShape Contour I system, 92% of patients experienced a measurable reduction in body circumference and 88% of patients expressed satisfaction with their results. The second trial (conducted from October 2006 through January 2007 on 24 patients) follows a three-treatment protocol, with shortened intervals between treatments, and has demonstrated preliminary results of successful mean circumferential reduction of 3.54 cm after only two treatments. Dr. Ascher commented, "My patients have been extremely satisfied with the pain-free, 'walk-in, walk out' nature of UltraShape procedure and the long-lasting fat reduction and body contouring effects. As an Aesthetic Surgeon, I am pleased both with the results my patients have experienced from UltraShape's innovative technology and the role that it has played as a growth engine for my clinic."

'/>"/>
SOURCE UltraShape Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
2. Video: New Research Discovers Independent Brain Networks Control Human Walking
3. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
4. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
5. IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
6. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
7. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
8. Multiple Dose Clinical Trial of TorreyPines Therapeutics Tezampanel Demonstrates Compound is Safe and Well-Tolerated
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
11. Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Nov. 20 In response to ...hy currently available medications designed to tre...I Institute, an independent nonprofit organization...eride for Prevention of Prostate Cancer for free... Times article, " Drugs to Deter Some Cancers Are...
(Date:11/19/2009)...9 BioCryst Pharmaceutica...ing of a public offering of 5,000,000 shares of it...oss proceeds of $48.75 million. All of the shares...ctive shelf registration statement previously file...oCryst has also granted the underwriters a 30-day ...
(Date:11/19/2009)...wswire/ -- Riverain Medical announced today that t...n medical imaging distributor Christie Group to of...est Xray CAD. The exclusive agreement will bring D...he Canadian market through Christie Group,s establ...Enhanced Chest Imaging increases the clarity of di...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 1Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 2Announcing the Launch of Chemo Couture com 52111 1Derma Sciences Inc Hires the Investor Relations Group 13090 1Derma Sciences Inc Hires the Investor Relations Group 13090 2Derma Sciences Inc Hires the Investor Relations Group 13090 3
...ociation for Cancer Research meeting indicate tha...on of non-water-soluble drugs to treat cancer and...16 Celator Pharmaceuticals today,reported results...t are,incapable of dissolving in water (hydrophobi...rug circulation. These findings allow the company ...
... A new Mayo,Clinic study found that regular physic...e impairment, a disorder of the brain that affects...study will be presented at the,American Academy of... Individuals with mild cognitive impairment can f...t often have difficulty remembering details of,con...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2
(Date:11/21/2009)...e medical apparel company launches men,s lab coats... San Clemente, Calif. (PRWEB) November 21, 2009...pparel, today announced the launch of its men,s la...ading international trade fair for the medical ind...rates its men,s collection with three varying lab ...
(Date:11/21/2009)...all, president and chief executive officer of the ... following statement regarding the inclusion of co...nual wellness for Medicare beneficiaries in "...t; that was introduced last night: , ... -- Eric J. Hall, president and chief executive of...
(Date:11/21/2009)...roup ask whether there is a secret to ,alcohol reh... London, UK (PRWEB) November 21, 2009 ...ee of the adult UK population drinking enough alco... liver disease*, it is hardly a surprise that many...mmes and residential centres for help. However, fo...
(Date:11/20/2009).../PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals C...reholders will be held on Monday, December 21, 200...val of two special resolutions. The first special ... all or substantially all of the assets of NUCRYST...sset purchase agreement dated November 10, 2009 am...
(Date:11/20/2009)... The United States Conf...e essential changes its health reform bill in orde... and conscience protection on abortion, protect ac...ong provisions for adequate affordability. ,, T...enormous disappointment" that creates new and unac...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
... time coping with winter,s chill, experts warn , ... adults should take additional precautions to pres...ing to the American Geriatric Society,s Foundation...rmia, frostbite, falls, injury while shoveling sno...
...can help everyone uncork a merry celebration , ...u pop the cork on the bottle of bubbly to celebrat...t eye injuries, says the American Academy of Ophth...respondent for the academy, said in a prepared sta...
... Ranbaxy Laboratories Limited,(RLL), announced to...rom,the U.S. Food and Drug Administration to manuf... (OTC), 5 mg and 10 mg. The Office of Generic Drug...nce,listed drug Zyrtec(R) Allergy tablets, 5mg and...
...tists at Jeffersons Kimmel Cancer Center in Philad... key to prostate cancer cell growth is turned on i...esistant to hormone therapy. If the findings hold ...arja Nevalainen, M.D., Ph.D., associate professor ...
...y to avoiding complications, doctors say , ...d more American children are diagnosed with type 2...their health. , Children and teens diagnosed with... The findings underscore the importance of prevent...
...reate more than 500 Jobs, HARRISBURG, Pa., Dec. 2...is jump-starting an expansion of the Butler,Memori...ute care tower and,on- and off-site road improveme...aid will come in the form of an annual grant of $6...
Other Medicine News:Health News:Seasonal Safety Tips for Older Adults 2Health News:Seasonal Safety Tips for Older Adults 3Health News:See to It That New Year's Eve Is Safe 2Health News:Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg 2Health News:Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer 2Health News:Childhood Diabetes Boosts Risk for Kidney Problems 2Health News:Childhood Diabetes Boosts Risk for Kidney Problems 3Health News:Pennsylvania Invests $13.4 Million to Kick Off Butler Memorial Hospital Expansion 2
Arrow HexaPolar EP Catheter
Inquiry Steerable Diagnostic Catheters
Envoy
Mayfield Triad Skull Clamp
Medicine Products: